The Role of non-coding RNAs in colorectal cancer, with a focus on its autophagy

L Chen, M He, M Zhang, Q Sun, S Zeng, H Zhao… - Pharmacology & …, 2021 - Elsevier
Colorectal cancer (CRC) is one of malignant afflictions burdening people worldwide, mainly
caused by shortages of effective medical intervention and poorly mechanistic understanding …

Functions of the aryl hydrocarbon receptor (AHR) beyond the canonical AHR/ARNT signaling pathway

NC Sondermann, S Faßbender, F Hartung… - Biochemical …, 2023 - Elsevier
The aryl hydrocarbon receptor (AHR) is a ligand-dependent transcription factor regulating
adaptive and maladaptive responses toward exogenous and endogenous signals …

Anti-inflammatory function of plant-derived bioactive peptides: A review

W Liu, X Chen, H Li, J Zhang, J An, X Liu - Foods, 2022 - mdpi.com
Inflammation is considered to be a crucial factor in the development of chronic diseases,
eight of which were listed among the top ten causes of death worldwide in the World Health …

Alopecia areata–Current understanding and management

DA Lintzeri, A Constantinou, K Hillmann… - JDDG: Journal der …, 2022 - Wiley Online Library
Alopecia areata (AA) is a chronic, immune‐mediated disease characterized by acute or
chronic non‐scarring hair loss, with a heterogeneity in clinical manifestations ranging from …

Natural anti-inflammatory compounds as drug candidates for inflammatory bowel disease

L Duan, S Cheng, L Li, Y Liu, D Wang… - Frontiers in …, 2021 - frontiersin.org
Inflammatory bowel disease (IBD) represents chronic recurrent intestinal inflammation
resulting from various factors. Crohn's disease (CD) and ulcerative colitis (UC) have been …

[HTML][HTML] Upadacitinib therapy reduces ulcerative colitis symptoms as early as day 1 of induction treatment

EV Loftus Jr, JF Colombel, K Takeuchi, X Gao… - Clinical …, 2023 - Elsevier
Background & Aims We evaluated the efficacy of once-daily (QD) upadacitinib 45 mg, an
oral, reversible Janus kinase inhibitor, on early symptomatic improvement for ulcerative …

Development of Spleen Targeting H2S Donor Loaded Liposome for the Effective Systemic Immunomodulation and Treatment of Inflammatory Bowel Disease

C Oh, W Lee, J Park, J Choi, S Lee, S Li, HN Jung… - ACS …, 2023 - ACS Publications
Nanoparticles are primarily taken up by immune cells after systemic administration. Thus,
they are considered an ideal drug delivery vehicle for immunomodulation. Because the …

The emerging role of Janus kinase inhibitors in the treatment of autoimmune and inflammatory diseases

W Damsky, D Peterson, J Ramseier… - Journal of Allergy and …, 2021 - Elsevier
Autoimmune and inflammatory diseases are common and diverse, and they can affect
nearly any organ system. Much of the pathogenesis of these diseases is related to …

Immunomodulatory biomaterials and their application in therapies for chronic inflammation-related diseases

JR Nakkala, Z Li, W Ahmad, K Wang, C Gao - Acta Biomaterialia, 2021 - Elsevier
The degree of tissue injuries such as the level of scarring or organ dysfunction, and the
immune response against them primarily determine the outcome and speed of healing …

The JAK/STAT pathway and its selective inhibition in the treatment of atopic dermatitis: a systematic review

A Tsiogka, M Kyriazopoulou… - Journal of Clinical …, 2022 - mdpi.com
In recent years, the broadening understanding of the pathogenesis of atopic dermatitis (AD)
has led to the development of novel therapeutic molecules, that target core inflammatory …